Phase II Study Evaluating Treatment With Oral Navelbine [vinorelbine] and Cisplatin Administered Weekly and Concomitant Radiotherapy in Elderly Patients With no Operable NSCLC.

Trial Profile

Phase II Study Evaluating Treatment With Oral Navelbine [vinorelbine] and Cisplatin Administered Weekly and Concomitant Radiotherapy in Elderly Patients With no Operable NSCLC.

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Jun 2018

At a glance

  • Drugs Cisplatin (Primary) ; Vinorelbine (Primary)
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Acronyms RACCOSA
  • Most Recent Events

    • 05 Jun 2018 Results evaluating the ability of a comprehensive geriatric assessment (CGA) to select the elderly La-NSCLC patients who potentially may benefit from concurrent radio-chemotherapy presented at the 54th Annual Meeting of the American Society of Clinical Oncology
    • 01 May 2018 Status changed from active, no longer recruiting to completed.
    • 09 Mar 2015 Planned End Date changed from 1 Jan 2016 to 1 Jun 2016 as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top